International Scholarly Research Notices / 2011 / Article / Fig 3

Research Article

Switching from Intravitreal Ranibizumab to Bevacizumab for Age-Related Macular Degeneration

Figure 3

The mean foveal retinal thickness (FRT) at the followup visits and prior to switching treatment. A significant difference was noted at six weeks, six months, and at the final visit compared with the value before the switch (*The Wilcoxon signed-rank test: 𝑃 < 0 . 0 1 ).

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.